By Devika Patel
Knoxville, Tenn., July 21 - Optimer Pharmaceuticals, Inc. said it has received commitments for a $12.24 million direct offering of shares.
The company will sell 1,443,396 common shares at $8.48 per share.
Settlement is expected July 25.
Proceeds will be used for development and general corporate purposes.
San Diego-based Optimer Pharmaceuticals is a biopharmaceutical company specializing on the discovery, development and commercialization of innovative treatments.
| Issuer: | Optimer Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $12,239,998.08
|
| Shares: | 1,443,396
|
| Price: | $8.48
|
| Warrants: | No
|
| Pricing date: | July 21
|
| Settlement date: | July 25
|
| Stock symbol: | Nasdaq: OPTR
|
| Stock price: | $8.52 at close July 18
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
